Deux biobanques pour lutter contre la COVID-19
Face à la pandémie de COVID-19, deux biobanques ont rapidement été mises sur pied pour faciliter la recherche. Comment en apprendre davantage sur le virus SARS-CoV-2 et ses impacts sur
McGill Genome Centre fosters partnership between Canada and UK on COVID genomic research
Partnership will support efforts to sequence and analyze the spread and evolution of the SARS-CoV-2 virus and how it affects patients Over the last weeks, the McGill Genome Centre has established a
The COVID-19 Genomics UK (COG-UK) consortium and the Canadian COVID Genomics Network (CanCOGeN) launch new partnership
COG-UK and CanCOGeN are working together to share knowledge and protocols The COVID-19 Genomics UK (COG-UK) consortium is collaborating with the newly formed Canadian COVID Genomics Network (CanCOGeN) as it launches a
Social Science and Humanities researchers also active in battle against COVID
McGill’s SSHRC Institutional Grant and MI4 co-fund 12 projects exploring the social dimension of the COVID-19 pandemic. Twelve McGill researchers are the recipients of a total of $179,258 in one-time
The Quebec COVID-19 Biobank – an essential weapon against COVID
Inter-institutional initiative is similar to other efforts abroad to catalogue samples gathered from COVID-19 patients, but the quality of the data and samples, as well as the long-term focus of
New partnership to unravel genetic sequence of SARS-CoV-2 virus in Quebec
The Institut national de santé publique du Québec (INSPQ) and the McGill Genome Centre partner to sequence SARS-CoV-2 genomes identified in Québec and better understand the disease The Institut national de
L’INSPQ et le Centre de génomique de McGill : partenaires pour le séquençage génétique du SARS-CoV-2 au Québec
L’Institut national de santé publique du Québec se joint au Centre de génomique de l’Université McGill afin de séquencer les différentes souches virales des patients québécois atteints par la COVID-19.
Des tests sanguins nécessaires : entrevue avec Vincent Poitout, directeur de la recherche du CHUM
https://www.tvanouvelles.ca/videos/6152200213001
CanCOVID speaker series – Dr. Vincent Mooser giving an update on the Covid-19 Quebec Biobank
Dr. Vincent Mooser is the first speaker in the CanCOVID speaker series. Dr. Mooser provides an update on the Covid-19 Quebec Biobank:
Le groupe sanguin influe-t-il sur la sévérité de la COVID-19?
Q: «On dit que les gens du type O négatif sont plus résistants face à ce virus. Qu’en est-il vraiment?», demande Charles St-Amand. https://www.latribune.ca/actualites/vos-questions-sur-la-covid-19/le-groupe-sanguin-influe-t-il-sur-la-severite-de-la-covid-19-f9efccedd1146a79cb55bc575e72684f